D-Index & Metrics Best Publications

Lourdes Santana

University of Santiago de Compostela
Spain

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Chemistry D-index 52 Citations 8,224 226 World Ranking 9922 National Ranking 370

Overview

What is she best known for?

The fields of study Lourdes Santana is best known for:

Enzyme
Gene
DNA

Her Bioinformatics study in the realm of Proteome interacts with subjects such as Computational biology. Her Bioinformatics study frequently draws connections between adjacent fields such as Annotation and Proteome. Computational biology and Genetics are two areas of study in which Lourdes Santana engages in interdisciplinary research. Many of her studies on Genetics apply to Annotation as well. Her Drug research also covers Drug-drug interaction, Drug interaction and Pharmacovigilance studies. Her research on Drug-drug interaction often connects related topics like Drug. Lourdes Santana integrates Biochemistry with In silico in her study. Her study ties her expertise on Chalcone together with the subject of Organic chemistry. Stereochemistry is frequently linked to Molecular descriptor in her study.

Her most cited work include:

Medicinal Chemistry and Bioinformatics - Current Trends in Drugs Discovery with Networks Topological Indices (248 citations)
Proteomics, networks and connectivity indices (209 citations)
Drug—drug interaction through molecular structure similarity analysis (152 citations)

What are the main themes of her work throughout her whole career to date

Her In vitro research is covered under the topics of Chemical synthesis and Structure–activity relationship. Her study on Structure–activity relationship is mostly dedicated to connecting different topics, such as In vitro. Her research ties Antioxidant and Biochemistry together. Her Stereochemistry study frequently draws connections between adjacent fields such as Quantitative structure–activity relationship. Lourdes Santana regularly links together related areas like Stereochemistry in her Quantitative structure–activity relationship studies. Her work blends Organic chemistry and Combinatorial chemistry studies together. She merges Combinatorial chemistry with Organic chemistry in her study. She integrates Coumarin with Enzyme in her study. She incorporates Enzyme and Monoamine oxidase in her research.

Lourdes Santana most often published in these fields:

Biochemistry (68.07%)
Stereochemistry (62.18%)
Organic chemistry (56.30%)

What were the highlights of her more recent work (between 2017-2021)?

Coumarin (83.33%)
Organic chemistry (83.33%)
Biochemistry (83.33%)

In recent works Lourdes Santana was focusing on the following fields of study:

Her work in Hybrid covers topics such as Botany which are related to areas like Coumarin. She regularly ties together related areas like Botany in her Coumarin studies. Her Lead compound research includes elements of Structure–activity relationship and Pharmacology. Lourdes Santana connects Pharmacology with Lead compound in her research. Her Organic chemistry study frequently intersects with other fields, such as Quinoline. She performs multidisciplinary study on Biochemistry and Computational biology in her works. She performs integrative study on Computational biology and Biochemistry. Lourdes Santana undertakes multidisciplinary investigations into Combinatorial chemistry and Drug discovery in her work. She integrates Drug discovery with Combinatorial chemistry in her research.

Between 2017 and 2021, her most popular works were:

Trending Topics on Coumarin and Its Derivatives in 2020 (60 citations)
Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins (50 citations)
Coumarin derivatives as promising xanthine oxidase inhibitors (40 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity.

F. Borges;F. Roleira;N. Milhazes;L. Santana.
Current Medicinal Chemistry (2005)

1063 Citations

Medicinal chemistry and bioinformatics--current trends in drugs discovery with networks topological indices.

Humberto Gonzalez-Diaz;Santiago Vilar;Lourdes Santana;Eugenio Uriarte.
Current Topics in Medicinal Chemistry (2007)

331 Citations

Proteomics, networks and connectivity indices.

Humberto González-Díaz;Yenny González-Díaz;Lourdes Santana;Florencio M. Ubeira.
Proteomics (2008)

305 Citations

A Novel Approach for the Virtual Screening and Rational Design of Anticancer Compounds

E Estrada;E Uriarte;A Montero;M Teijeira.
Journal of Medicinal Chemistry (2000)

230 Citations

Furocoumarins in medicinal chemistry. Synthesis, natural occurrence and biological activity.

L. Santana;E. Uriarte;F. Roleira;N. Milhazes.
Current Medicinal Chemistry (2004)

206 Citations

A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.

Lourdes Santana;Eugenio Uriarte;Humberto González-Díaz;Giuseppe Zagotto.
Journal of Medicinal Chemistry (2006)

189 Citations

Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids.

Santiago Vilar;Elías Quezada;Lourdes Santana;Eugenio Uriarte.
Bioorganic & Medicinal Chemistry Letters (2006)

183 Citations

Drug—drug interaction through molecular structure similarity analysis

Santiago Vilar;Santiago Vilar;Rave Harpaz;Eugenio Uriarte;Lourdes Santana.
Journal of the American Medical Informatics Association (2012)

159 Citations

Similarity-based modeling in large-scale prediction of drug-drug interactions

Santiago Vilar;Eugenio Uriarte;Lourdes Santana;Tal Lorberbaum.
Nature Protocols (2014)

152 Citations

Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.

Maria J Matos;Carmen Terán;Yunierkis Pérez-Castillo;Eugenio Uriarte.
Journal of Medicinal Chemistry (2011)